Who invested in Jounce Therapeutics?
Jounce Therapeutics's investors include Wellington Management, Cormorant Asset Management, Redmile Group, Foresite Capital and Casdin Capital, and 4 more on record.
United States · Series B startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$103Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $56M sold, first sale Apr 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Jounce Therapeutics's investors include Wellington Management, Cormorant Asset Management, Redmile Group, Foresite Capital and Casdin Capital, and 4 more on record.
Jounce Therapeutics has raised $103M across 2 rounds since 2013.
Jounce Therapeutics's most recent round was a Series B of $56M in Apr 2015.
Its most recent round, $56M in Apr 2015, is also its largest on record.
Jounce Therapeutics's first round on record, in Feb 2013, was backed by Third Rock Ventures.
Jounce Therapeutics's latest named round is a Series B, in Apr 2015.
Jounce Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.